In the early 1980s, HIV was a death sentence. Now, treatments exist to manage it, but some individuals, known as elite controllers, never progress to AIDS without treatment. These rare individuals make up less than 0.5 percent of all HIV patients. Their unique immune response could hold the key to a lasting cure. Diana Kwon explores their resistance and its potential implications. This month’s Highlight cover story delves into what makes these 'elite controllers' different, how their HIV resistance functions, and whether it’s replicable for others. Additionally, the issue covers young men and Viagra, sports gambling’s table tennis mania, how robots are revolutionizing mastectomy surgery, and climate-proofing conservation. Understanding the immune systems of these elite controllers could lead to groundbreaking advancements in HIV treatment and potentially a cure. #HIV #EliteControllers #MedicalResearch #Health
También lo cubren: vox.com - Vox (Estados Unidos).
Ver más en NewsToday